DEVON ENERGY CORP (DVN)       60.85  -0.1 (-0.16%)

60.85  -0.1 (-0.16%)

US25179M1036 - Common Stock - After market: 60.9 +0.05 (+0.08%)


Fundamental Rating

7

Taking everything into account, DVN scores 7 out of 10 in our fundamental rating. DVN was compared to 391 industry peers in the Oil, Gas & Consumable Fuels industry. DVN has a great profitability rating, but there are some minor concerns on its financial health. DVN is growing strongly while it is still valued neutral. This is a good combination!




Profitability

Profitability Rating

8

DVN's Return On Assets of 26.54% is amongst the best returns of the industry. DVN outperforms 84% of its industry peers. The industry average Return On Assets is 12.18%.
DVN has a Return On Equity of 57.49%. This is amongst the best returns in the industry. The industry average is 26.95%. DVN outperforms 86% of its industry peers.

DVN's Profit Margin of 32.65% is amongst the best of the industry. DVN does better than the industry average Profit Margin of 25.51%.
The Piotroski-F score of DVN is 7.00. This is a strong score and indicates good health and profitability for DVN.
VS Industry

ROA (26.54%) VS Industry: 84% outperformed.

0.06
1,189.87

ROE (57.49%) VS Industry: 86% outperformed.

0.24
5,310.48

Profit Margin (32.65%) VS Industry: 64% outperformed.

0.07
268.29

Valuation

Valuation Rating

6

With a Price/Earnings Ratio of 7.57, the valuation of DVN can be described as very cheap.
With a Forward Price/Earnings Ratio of 6.62, the valuation of DVN can be described as cheap.
DVN's low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
When comparing the current price to the book value of DVN, we can conclude it is valued correctly. It is trading at 3.66 times its book value.

When comparing the Enterprise Value to EBITDA ratio of DVN to the average industry ratio of 4.05, DVN is valued in line with its industry peers.
Compared to an average industry Price/Earning Ratio of 6.45, DVN is valued slightly more expensive.
Compared to an average industry price book ratio of 1.57, DVN is valued more expensive than its industry peers. 81% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (7.57) VS Industry: 40% outperformed.

1,200.00
0.06

Price/Book (3.66) VS Industry: 19% outperformed.

3,359.10
0.04

Enterprise Value/ EBITDA (4.41) VS Industry: 46% outperformed.

242.49
0.24

Growth

Growth Rating

7

DVN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 277.46%, which is quite impressive.
DVN shows a strong growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 39.74% yearly.
DVN shows a strong growth in Revenue. In the last year, the Revenue has grown by 114.49%.
The Revenue is expected to grow by 19.42% on average over the next 5 years. This is quite good.

When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
Based on estimates for the next 5 years, DVN will show a small growth in Earnings Per Share. The EPS will grow by 9.59% on average per year.
Measured over the past 5 years, DVN shows a small growth in Revenue. The Revenue has been growing by 3.45% on average per year.
The EPS growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A 39.74% 277.46% 151.56% 61.55% 31.74% 9.59%
Revenue3.45% 11.12% 114.49% 70.03% 31.14% 19.42% N/A

Health

Health Rating

6

An Altman-Z score of 4.09 indicates that DVN is not in any danger for bankruptcy at the moment.
DVN is in better financial health than average in its industry. Its Altman-Z score is much better than the industry average of 2.13.
DVN has a good Piotroski-F score of 7.00. This indicates a good health and good profitability for DVN.
DVN has a Current Ratio of 1.16. This is a normal value and indicates that DVN is financially healthy and should not expect problems in meeting its short term obligations.

The Current Ratio is in line with the industry averages, which is at 1.11.
DVN has a Quick Ratio of 1.16. This is a normal value and indicates that DVN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick Ratio is in line with the industry averages, which is at 0.95.
When comparing the Debt to Equity Ratio of DVN to the average industry Debt to Equity Ratio of 0.29, DVN required more debt to finance its operations than its industry peers.
VS Industry

Debt/Equity (0.59) VS Industry: 32% outperformed.

31.33
0.00

Quick Ratio (1.16) VS Industry: 58% outperformed.

0.00
297.28

Current Ratio (1.16) VS Industry: 51% outperformed.

0.00
297.28

Altman-Z (4.09) VS Industry: 74% outperformed.

-283,883.15
1,024.97

Dividend

Dividend Rating

8

With a Yearly Dividend Yield of 7.98%, DVN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 5.56, DVN pays a bit more dividend than its industry peers.
DVN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.41.
The dividend of DVN is nicely growing with an annual growth rate of 87.26%!

DVN has paid a dividend for at least 10 years, which is a reliable track record.
DVN pays out 48.92% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of DVN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
VS Industry

Dividend Yield (7.98%) VS Industry: 75% outperformed.

0.34
64.51

DEVON ENERGY CORP60.85

NYSE:DVN (2/3/2023, 7:04:00 PM)-0.1 (-0.16%)

After market: 60.9 +0.05 (+0.08%)

Chartmill FA Rating
GICS Sector Energy
GICS IndustryGroup Energy
GICS Industry Oil, Gas & Consumable Fuels
Earnings (Last) 11-01 2022-11-01/amc Earnings (Next) 02-13 2023-02-13/amc
Inst Owners 79.68% Inst Owner Change 0.13%
Ins Owners 0.79% Ins Owner Change 5.34%
Market Cap 39.78B Analysts 75.43
Price Target 79.65 (30.9%)

Dividend
Industry RankSector Rank
Dividend Yield 7.98%
Dividend Growth(5Y) 87.26% DP 48.92%
Div Incr Years 5 Div Non Decr Years 5
Ex-Date N/A

Surprises & Revisions
EPS beat(2) 2 Avg EPS beat(2) 4.67%
Min EPS beat(2) 1.67% Max EPS beat(2) 7.67%
EPS beat(4) 4 Avg EPS beat(4) 6.72%
Min EPS beat(4) 1.67% Max EPS beat(4) 10.98%
Revenue beat(2) 2 Avg Revenue beat(2) 12.46%
Min Revenue beat(2) 8.55% Max Revenue beat(2) 16.36%
Revenue beat(4) 3 Avg Revenue beat(4) 8.43%
Min Revenue beat(4) -3.59% Max Revenue beat(4) 16.36%
PT rev (1m) -1.84% PT rev (3m) -3.18%
EPS NQ rev (1m) -10.78% EPS NQ rev (3m) -20.04%
EPS NY rev (1m) 0% EPS NY rev (3m) -5.87%
Revenue NQ rev (1m) -10.09% Revenue NQ rev (3m) -13.57%
Revenue NY rev (1m) 0% Revenue NY rev (3m) 0.35%

Valuation
Industry RankSector Rank
PE 7.57
Fwd PE 6.62
P/S 2.08
P/FCF 11.72
P/OCF 4.84
P/B 3.66
P/tB 3.93
EV/EBITDA 4.41
EPS(TTM) 8.04 EY 13.21%
EPS(NY) 9.19 Fwd EY 15.1%
FCF(TTM) 5.19 FCFY 8.53%
OCF(TTM) 12.57 OCFY 20.65%
SpS 29.28 BVpS 16.63
TBVpS 15.48 PEG (NY) 0.05
PEG (5Y) N/A

Profitability
Industry RankSector Rank
ROA 26.54%
ROE 57.49%
ROIC 31.75%
ROICexc 33.96%
ROICexgc 35.38%
OM 42.19%
PM 32.65%
GM 55.59%
ROICexgc(3y) N/A ROICexcg growth 3Y 27.49%
ROICexcg growth 5Y N/A ROICexc(3y) N/A
ROICexc growth 3Y 27.87% ROICexc growth 5Y N/A
OM growth 3Y 16.94% OM growth 5Y N/A
PM growth 3Y -12.77% PM growth 5Y N/A
GM growth 3Y -18.1% GM growth 5Y -10.33%
F-Score 7 Asset Turnover 0.81

Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 1.98
Debt/EBITDA 0.65
Cap/Depr 221.56%
Profit Quality 54.31%
Current Ratio 1.16
Quick Ratio 1.16
Altman-Z 4.09
F-Score 7 WACC 12.42%
ROIC/WACC 2.85 Cap/Depr(3y) 103.99%
Cap/Depr(5y) 130.65% Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y 277.46% EPS 3Y 39.74%
EPS 5Y N/A EPS growth Q2Q 101.85%
EPS Next Y 151.56% EPS Next 2Y 61.55%
EPS Next 3Y 31.74% EPS Next 5Y 9.59%
Revenue growth 1Y 114.49% Revenue growth 3Y 11.12%
Revenue growth 5Y 3.45% Revenue growth Q2Q 56.72%
Revenue Next Year 70.03% Revenue Next 2Y 31.14%
Revenue Next 3Y 19.42% Revenue Next 5Y N/A
EBIT growth 1Y 420.09% EBIT growth 3Y 29.95%
EBIT growth 5Y N/A EBIT Next Year 201.79%
EBIT Next 3Y 42.06% EBIT Next 5Y 28.75%
FCF growth 1Y 1650% FCF growth 3Y 75.72%
FCF growth 5Y N/A OCF growth 1Y 431.31%
OCF growth 3Y 21.91% OCF growth 5Y 26.71%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA